Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taha Merghoub

Showing results (1-10 of 216) with videos related to

Pageof 22
Sort By:
Translational Cancer Research|October 11, 2019
Interfering with Helios-induced regulatory T cell stability as a strategy for cancer immunotherapyRoberta Zappasodi, Taha Merghoub
The Journal of Pharmacology and Experimental Therapeutics|February 23, 2023
Paving the Way for Cancer Therapy a Nano Step at a TimeDivya Venkatesh, Taha Merghoub
Immunotherapy|August 28, 2015
Alphavirus-based vaccines in melanoma: rationale and potential improvements in immunotherapeutic combinationsRoberta Zappasodi, Taha Merghoub
The Journal of Experimental Medicine|November 19, 2014
Immunotherapy and the belly of the beastTaha Merghoub, Jedd D Wolchok
Annals of Translational Medicine|January 5, 2018
Antiangiogenic therapy and immune checkpoint blockade go hand in handLuis Felipe Campesato, Taha Merghoub
Cell|June 3, 2017
Curbing Tregs' (Lack of) EnthusiasmTaha Merghoub, Jedd D Wolchok
Hepatobiliary Surgery and Nutrition|June 28, 2019
One checkpoint may hide another: inhibiting the TGFβ signaling pathway enhances immune checkpoint blockadeAditi Gupta, Sadna Budhu, Taha Merghoub
Frontiers in Immunology|November 8, 2021
Editorial: Dynamic Biomarkers of Response to Anti-Immune Checkpoint Inhibitors in CancerSaid Dermime, Maysaloun Merhi, Taha Merghoub
Current Opinion in Genetics & Development|March 25, 2014
The importance of animal models in tumor immunity and immunotherapySadna Budhu, Jedd Wolchok, Taha Merghoub
Cancer Cell|October 10, 2018
Emerging Concepts for Immune Checkpoint Blockade-Based Combination TherapiesRoberta Zappasodi, Taha Merghoub, Jedd D Wolchok
Pageof 22

Showing results (1-10 of 216) with videos related to

Sort By:
Pageof 22
Translational Cancer Research|October 11, 2019
Interfering with Helios-induced regulatory T cell stability as a strategy for cancer immunotherapyRoberta Zappasodi, Taha Merghoub
The Journal of Pharmacology and Experimental Therapeutics|February 23, 2023
Paving the Way for Cancer Therapy a Nano Step at a TimeDivya Venkatesh, Taha Merghoub
Immunotherapy|August 28, 2015
Alphavirus-based vaccines in melanoma: rationale and potential improvements in immunotherapeutic combinationsRoberta Zappasodi, Taha Merghoub
The Journal of Experimental Medicine|November 19, 2014
Immunotherapy and the belly of the beastTaha Merghoub, Jedd D Wolchok
Annals of Translational Medicine|January 5, 2018
Antiangiogenic therapy and immune checkpoint blockade go hand in handLuis Felipe Campesato, Taha Merghoub
Cell|June 3, 2017
Curbing Tregs' (Lack of) EnthusiasmTaha Merghoub, Jedd D Wolchok
Hepatobiliary Surgery and Nutrition|June 28, 2019
One checkpoint may hide another: inhibiting the TGFβ signaling pathway enhances immune checkpoint blockadeAditi Gupta, Sadna Budhu, Taha Merghoub
Frontiers in Immunology|November 8, 2021
Editorial: Dynamic Biomarkers of Response to Anti-Immune Checkpoint Inhibitors in CancerSaid Dermime, Maysaloun Merhi, Taha Merghoub
Current Opinion in Genetics & Development|March 25, 2014
The importance of animal models in tumor immunity and immunotherapySadna Budhu, Jedd Wolchok, Taha Merghoub
Cancer Cell|October 10, 2018
Emerging Concepts for Immune Checkpoint Blockade-Based Combination TherapiesRoberta Zappasodi, Taha Merghoub, Jedd D Wolchok
Pageof 22